Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis

Therapeutic Apheresis and Dialysis

Volumn 16, Issue 5, 2012, Pages 384-386

  Tsuruya, Kazuhiko ^a   Hirakata, Hideki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; ACETYLSALICYLIC ACID; ALTEPLASE; AMEZINIUM; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ARGATROBAN; ATRIAL NATRIURETIC FACTOR; BERAPROST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIASPIRIN; BRAIN NATRIURETIC PEPTIDE; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIGITALIS; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ETILEFRINE; GLYCEROL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICERITROL; NORPHENAZONE; OZAGREL; SARPOGRELATE; THREO 3,4 DIHYDROXYPHENYLSERINE; TICLOPIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; EDITORIAL; EXTRACELLULAR SPACE; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; INFLAMMATION; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; MALNUTRITION; ORTHOSTATIC HYPOTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SYSTOLIC BLOOD PRESSURE; TREATMENT CONTRAINDICATION; ACUTE CORONARY SYNDROME; ACUTE PANCREATITIS; ANEMIA; ANGINA PECTORIS; AORTA STENOSIS; ARTERIAL STIFFNESS; ARTERIAL WALL THICKENING; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTERIOVENOUS FISTULA; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL CALCIFICATION; BODY FLUID; BRADYCARDIA; BRAIN CIRCULATION; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTINUOUS HEMODIAFILTRATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY RECANALIZATION; DEFIBRILLATION; DEHYDRATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DRUG ELIMINATION; DRUG EXCRETION; DRY WEIGHT; DYSDIALYSIS SYNDROME; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; EMERGENCY CARE; EXERCISE; HEART ARREST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DEATH; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HEART PALPITATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HEMOFILTRATION; HEPATOMEGALY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERVOLEMIA; HYPOALBUMINEMIA; HYPOCHOLESTEROLEMIA; HYPOGLYCEMIA; HYPOLIPEMIA; HYPOPROTEINEMIA; HYPOTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFERIOR CAVA VEIN; INTRADIALYTIC HYPOTENSION; KIDNEY FAILURE; LIFESTYLE MODIFICATION; LUNG CONGESTION; MAGNETIC RESONANCE ANGIOGRAPHY; META ANALYSIS (TOPIC); MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MYOCARDIAL PERFUSION IMAGING; NEPHROTIC SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLEURA EFFUSION; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; SUDDEN DEATH; TACHYCARDIA; THORAX RADIOGRAPHY; ULTRAFILTRATION; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; HUMANS; JAPAN; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; SOCIETIES, MEDICAL; KIDNEY FAILURE, CHRONIC; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL;

EID: 84867358230     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2012.01117.x     Document Type: Editorial

References (18)

1. Statistical Survey Committee, Japanese Society for Dialysis Therapy. Current state of chronic dialysis treatment in Japan, illustrated (as of Dec. 31, 2011). Japanese Society for Dialysis Therapy, 2012.
2. Wanner C, Krane V, Marz W etal. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-48.
3. Fellstrom BC, Jardine AG, Schmieder RE etal. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009;360:1395-407.
4. Baigent C, Landray MJ, Reith C etal. The effects of lowering LDL cholesterol with simvastatin plus ezemitibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 2011;377:2181-92.
5. Marz W, Genser B, Drechsler C etal. Atorvastatin and low density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol 2011;6:1316-25.
6. Holdaas H, Holme I, Schmieder RE etal. Rosuvastatin in diabetic hemodialysis patients. J Am Soc Nephrol 2011;22:1335-41.
7. Nakai S, Masakane I, Akiba T etal. An overview of dialysis treatment in Japan (as of Dec. 31, 2005). J Jpn Soc Dial Ther 2007;40:1-30.
8. Ogihara T, Kikuchi K, Matsuoka H etal.; Japanese Society of Hypertension Committee. The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009;32:3-107.
9. Iseki K, Miyasato F, Tokuyama K etal. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997;51:1212-17.
10. Zager PG, Nikolic J, Brown RH etal. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998;54:561-9.
11. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patients survival. Kidney Int 2000;58:2147-54.
12. Charra B, Calemard E, Ruffet M etal. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-91.
13. Tomita J, Kimura G, Inoue T etal. Role of systolic blood pressure in determining prognosis of hemodialysis patients. Am J Kidney Dis 1995;25:405-12.
14. Moriya H, Oka M, Maesato K etal. Weekly averaged blood pressure is more important than a single-point blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol 2008;3:416-22.
15. Alborzi P, Patel N, Agarwal R. Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2007;2:1228-34.
16. Francis GS, Gassler JP, Sonnenblick EH. Pathophysiology and diagnosis of heart failure. In: Fuster V, Alexander RW, O'Rourke RA, eds. The Heart, 10th edn. New York: McGraw-Hill, 2001; 655.
17. Banerjee D, Ma JZ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol 2007;2:1186-90.
18. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009;20:2223-33.